1
Margulis, Andrea V., Houben, Eline, Hallas, Jesper, Overbeek, Jetty A., Pottegård, Anton, Torp-Pedersen, Tobias, Perez-Gutthann, Susana, Arana, Alejandro
Veröffentlicht in: Margulis , A V , Houben , E , Hallas , J , Overbeek , J A , Pottegård , A , Torp-Pedersen , T , Perez-Gutthann , S & Arana , A 2017 , ' Ophthalmic nepafenac use in the Netherlands and Denmark ' , Acta Ophthalmologica , vol. 95 , no. 5 , pp. 509-517 . https://doi.org/10.1111/aos.13468;
2017
Veröffentlicht in: Margulis , A V , Houben , E , Hallas , J , Overbeek , J A , Pottegård , A , Torp-Pedersen , T , Perez-Gutthann , S & Arana , A 2017 , ' Ophthalmic nepafenac use in the Netherlands and Denmark ' , Acta Ophthalmologica , vol. 95 , no. 5 , pp. 509-517 . https://doi.org/10.1111/aos.13468;
2017
2
3
Morales, Daniel R., Morant, Steve V., MacDonald, Thomas M., Mackenzie, Isla S., Doney, Alexander S.F., Mitchell, Lyn, Bennie, Marion, Robertson, Chris, Hallas, Jesper, Pottegard, Anton, Ernst, Martin Thomsen, Wei, Li, Nicholson, Lizzie, Morris, Carole, Ron, M. C., Overbeek, Jetty A., Smits, Elisabeth, Robert, W. V.
Veröffentlicht in: Morales , D R , Morant , S V , MacDonald , T M , Mackenzie , I S , Doney , A S F , Mitchell , L , Bennie , M , Robertson , C , Hallas , J , Pottegard , A , Ernst , M T , Wei , L , Nicholson , L , Morris , C , Ron , M C , Overbeek , J A , Smits , E & Robert , W V 2020 , ' Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands ' , Pharmacoepidemiology and Drug Safety , vol. 29 , no. 3 , pp. 296-305 . https://doi.org/10.1002/pds.4955;
2020
Veröffentlicht in: Morales , D R , Morant , S V , MacDonald , T M , Mackenzie , I S , Doney , A S F , Mitchell , L , Bennie , M , Robertson , C , Hallas , J , Pottegard , A , Ernst , M T , Wei , L , Nicholson , L , Morris , C , Ron , M C , Overbeek , J A , Smits , E & Robert , W V 2020 , ' Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands ' , Pharmacoepidemiology and Drug Safety , vol. 29 , no. 3 , pp. 296-305 . https://doi.org/10.1002/pds.4955;
2020